Bradbury JA - Search Results

1

The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo.

Wray JA, Sugden MC, Zeldin DC, Greenwood GK, Samsuddin S, Miller-Degraff L, Bradbury JA, Holness MJ, Warner TD, Bishop-Bailey D. Wray JA, et al. Among authors: bradbury ja. PLoS One. 2009 Oct 12;4(10):e7421. doi: 10.1371/journal.pone.0007421. PLoS One. 2009. PMID: 19823578 Free PMC article.

2

Analysis of the cytotoxic properties of linoleic acid metabolites produced by renal and hepatic P450s.

Moran JH, Mitchell LA, Bradbury JA, Qu W, Zeldin DC, Schnellmann RG, Grant DF. Moran JH, et al. Among authors: bradbury ja. Toxicol Appl Pharmacol. 2000 Nov 1;168(3):268-79. doi: 10.1006/taap.2000.9053. Toxicol Appl Pharmacol. 2000. PMID: 11042099

3

Cloning of CYP2J2 gene and identification of functional polymorphisms.

King LM, Ma J, Srettabunjong S, Graves J, Bradbury JA, Li L, Spiecker M, Liao JK, Mohrenweiser H, Zeldin DC. King LM, et al. Among authors: bradbury ja. Mol Pharmacol. 2002 Apr;61(4):840-52. doi: 10.1124/mol.61.4.840. Mol Pharmacol. 2002. PMID: 11901223

4

Inhibition of vascular smooth muscle cell migration by cytochrome p450 epoxygenase-derived eicosanoids.

Sun J, Sui X, Bradbury JA, Zeldin DC, Conte MS, Liao JK. Sun J, et al. Among authors: bradbury ja. Circ Res. 2002 May 17;90(9):1020-7. doi: 10.1161/01.res.0000017727.35930.33. Circ Res. 2002. PMID: 12016269

5

Molecular cloning and characterization of mouse CYP2J6, an unstable cytochrome P450 isoform.

Ma J, Bradbury JA, King L, Maronpot R, Davis LS, Breyer MD, Zeldin DC. Ma J, et al. Among authors: bradbury ja. Biochem Pharmacol. 2002 Nov 15;64(10):1447-60. doi: 10.1016/s0006-2952(02)01393-x. Biochem Pharmacol. 2002. PMID: 12417258

6

Pulmonary cytochrome P-450 2J4 is reduced in a rat model of acute Pseudomonas pneumonia.

Yaghi A, Bradbury JA, Zeldin DC, Mehta S, Bend JR, McCormack DG. Yaghi A, et al. Among authors: bradbury ja. Am J Physiol Lung Cell Mol Physiol. 2003 Nov;285(5):L1099-105. doi: 10.1152/ajplung.00039.2003. Epub 2003 Jul 25. Am J Physiol Lung Cell Mol Physiol. 2003. PMID: 12882760 Free article.

7

Up-regulation of endothelial nitric-oxide synthase by endothelium-derived hyperpolarizing factor involves mitogen-activated protein kinase and protein kinase C signaling pathways.

Wang H, Lin L, Jiang J, Wang Y, Lu ZY, Bradbury JA, Lih FB, Wang DW, Zeldin DC. Wang H, et al. Among authors: bradbury ja. J Pharmacol Exp Ther. 2003 Nov;307(2):753-64. doi: 10.1124/jpet.103.052787. Epub 2003 Sep 15. J Pharmacol Exp Ther. 2003. PMID: 12975498

8

Regulation of mouse renal CYP2J5 expression by sex hormones.

Ma J, Graves J, Bradbury JA, Zhao Y, Swope DL, King L, Qu W, Clark J, Myers P, Walker V, Lindzey J, Korach KS, Zeldin DC. Ma J, et al. Among authors: bradbury ja. Mol Pharmacol. 2004 Mar;65(3):730-43. doi: 10.1124/mol.65.3.730. Mol Pharmacol. 2004. PMID: 14978252

9

CYP2C44, a new murine CYP2C that metabolizes arachidonic acid to unique stereospecific products.

DeLozier TC, Tsao CC, Coulter SJ, Foley J, Bradbury JA, Zeldin DC, Goldstein JA. DeLozier TC, et al. Among authors: bradbury ja. J Pharmacol Exp Ther. 2004 Sep;310(3):845-54. doi: 10.1124/jpet.104.067819. Epub 2004 Apr 14. J Pharmacol Exp Ther. 2004. PMID: 15084647

10

Cloning, expression, and characterization of three new mouse cytochrome p450 enzymes and partial characterization of their fatty acid oxidation activities.

Wang H, Zhao Y, Bradbury JA, Graves JP, Foley J, Blaisdell JA, Goldstein JA, Zeldin DC. Wang H, et al. Among authors: bradbury ja. Mol Pharmacol. 2004 May;65(5):1148-58. doi: 10.1124/mol.65.5.1148. Mol Pharmacol. 2004. PMID: 15102943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page